98 related articles for article (PubMed ID: 21235326)
1. NANOG has a role in mesenchymal stem cells' immunomodulatory effect.
Sun Z; Han Q; Zhu Y; Li Z; Chen B; Liao L; Bian C; Li J; Shao C; Zhao RC
Stem Cells Dev; 2011 Sep; 20(9):1521-8. PubMed ID: 21235326
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1.
Zhu Y; Sun Z; Han Q; Liao L; Wang J; Bian C; Li J; Yan X; Liu Y; Shao C; Zhao RC
Leukemia; 2009 May; 23(5):925-33. PubMed ID: 19148141
[TBL] [Abstract][Full Text] [Related]
3. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2.
Pierantozzi E; Gava B; Manini I; Roviello F; Marotta G; Chiavarelli M; Sorrentino V
Stem Cells Dev; 2011 May; 20(5):915-23. PubMed ID: 20879854
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 Transduced Mesenchymal Stem Cells Have Profound Modulatory Effects on DCs and T Cells.
Daneshmandi S; Karimi MH; Pourfathollah AA
Iran J Immunol; 2017 Mar; 14(1):13-23. PubMed ID: 28341815
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
[TBL] [Abstract][Full Text] [Related]
6. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
[TBL] [Abstract][Full Text] [Related]
8. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate.
Koh SH; Baik W; Noh MY; Cho GW; Kim HY; Kim KS; Kim SH
Exp Neurol; 2012 Jan; 233(1):472-80. PubMed ID: 22119626
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells.
Windmolders S; De Boeck A; Koninckx R; Daniëls A; De Wever O; Bracke M; Hendrikx M; Hensen K; Rummens JL
J Mol Cell Cardiol; 2014 Jan; 66():177-88. PubMed ID: 24326234
[TBL] [Abstract][Full Text] [Related]
11. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
[TBL] [Abstract][Full Text] [Related]
12. Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB.
Dorronsoro A; Ferrin I; Salcedo JM; Jakobsson E; Fernández-Rueda J; Lang V; Sepulveda P; Fechter K; Pennington D; Trigueros C
Eur J Immunol; 2014 Feb; 44(2):480-8. PubMed ID: 24307058
[TBL] [Abstract][Full Text] [Related]
13. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients.
Lamas JR; Mucientes A; Lajas C; Fernández-Gutiérrez B; Lópiz Y; Marco F; Jover JA; Abásolo L; Rodriguez-Rodriguez L
Immunotherapy; 2019 Sep; 11(13):1107-1116. PubMed ID: 31378114
[No Abstract] [Full Text] [Related]
14. Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression.
Gu TT; Liu SY; Zheng PS
Am J Pathol; 2012 Aug; 181(2):652-61. PubMed ID: 22683467
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin.
Liu R; Wang Y; Zhao X; Yang Y; Zhang K
Eur J Dermatol; 2014; 24(5):560-7. PubMed ID: 25445090
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.
Yan Z; Zhuansun Y; Chen R; Li J; Ran P
Exp Cell Res; 2014 May; 324(1):65-74. PubMed ID: 24681107
[TBL] [Abstract][Full Text] [Related]
17. The influence of protein malnutrition on biological and immunomodulatory aspects of bone marrow mesenchymal stem cells.
Dos Santos GG; Batool S; Hastreiter A; Sartori T; Nogueira-Pedro A; Borelli P; Fock RA
Clin Nutr; 2017 Aug; 36(4):1149-1157. PubMed ID: 27623433
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells.
Trubiani O; Zalzal SF; Paganelli R; Marchisio M; Giancola R; Pizzicannella J; Bühring HJ; Piattelli M; Caputi S; Nanci A
J Cell Physiol; 2010 Oct; 225(1):123-31. PubMed ID: 20458727
[TBL] [Abstract][Full Text] [Related]
19. Nanog promotes osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2 by modulating bone morphogenetic protein (BMP) signaling.
Ogasawara T; Ohba S; Yano F; Kawaguchi H; Chung UI; Saito T; Yonehara Y; Nakatsuka T; Mori Y; Takato T; Hoshi K
J Cell Physiol; 2013 Jan; 228(1):163-71. PubMed ID: 22585661
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency.
Ball SG; Shuttleworth A; Kielty CM
Stem Cells; 2012 Mar; 30(3):548-60. PubMed ID: 22213560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
